Filing Flows › Aspen Aerogels (ASPN) › R&D spending
Aspen Aerogels (ASPN) R&D spending by quarter
Aspen Aerogels' R&D spending was $2.5M in Q3 2026 (third quarter 2026), -22% from Q2 2026. Over the last 7 quarters it ranged from $2.5M (Q3 2026) to $4.3M (Q1 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $2.5M | -22% | -0.6% |
| Q2 2026 | $3.2M | +17% | -16% |
| Q1 2026 | $2.7M | -3% | -37% |
| Q4 2025 | $2.8M | +12% | — |
| Q3 2025 | $2.5M | -34% | — |
| Q2 2025 | $3.8M | -12% | — |
| Q1 2025 | $4.3M | — | — |
Q3 2026 at a glance
Aspen Aerogels, Q3 2026: revenue $85.2M (+17% year over year), operating margin -8.4%, net loss $10.4M, operating cash flow −$3.8M. The chart follows the revenue to costs, profit and cash.
Questions
What is Aspen Aerogels' R&D spending?
Aspen Aerogels' R&D spending was $2.5M in Q3 2026 (third quarter 2026), -22% from Q2 2026.
How has Aspen Aerogels' R&D spending changed?
Over the last 7 quarters it ranged from $2.5M (Q3 2026) to $4.3M (Q1 2025).